tiprankstipranks
Trending News
More News >
RAPT Therapeutics (RAPT)
NASDAQ:RAPT
US Market
Advertisement

RAPT Therapeutics (RAPT) Technical Analysis

Compare
393 Followers

Technical Sentiment

Overall Consensus
Strong Buy
14Bullish
6Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
RAPT Therapeutics’s (RAPT) Moving Averages Convergence Divergence (MACD) indicator is 3.07, suggesting RAPT Therapeutics is a Buy.
RAPT Therapeutics’s (RAPT) 20-Day exponential moving average is 27.55, while RAPT Therapeutics’s (RAPT) share price is $30, making it a Buy.
RAPT Therapeutics’s (RAPT) 50-Day exponential moving average is 22.00, while RAPT Therapeutics’s (RAPT) share price is $30, making it a Buy.

RAPT Therapeutics (RAPT) Pivot Points

Oct 25, 2025, 01:41 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.61
29.78
31.66
33.83
35.70
37.87
39.75
Fibonacci
29.78
31.33
32.28
33.83
35.37
36.33
37.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

RAPT Therapeutics (RAPT) Moving Averages

Oct 25, 2025, 01:41 AM
Period
Simple
Exponential
MA5
31.09Sell
30.79Sell
MA10
29.07Buy
29.72Buy
MA20
28.44Buy
27.55Buy
MA50
19.88Buy
22.00Buy
MA100
14.71Buy
17.38Buy
MA200
11.70Buy
14.11Buy
RAPT Therapeutics’s (RAPT) 10-Day exponential moving average is 29.72, while RAPT Therapeutics’s (RAPT) share price is $30, making it a Buy.
RAPT Therapeutics’s (RAPT) 100-Day exponential moving average is 17.38, while RAPT Therapeutics’s (RAPT) share price is $30, making it a Buy.
RAPT Therapeutics’s (RAPT) stock price is $30 and RAPT Therapeutics’s (RAPT) 50-day simple moving average is 19.88, creating a Buy signal.
RAPT Therapeutics’s (RAPT) stock price is $30 and RAPT Therapeutics’s (RAPT) 100-day simple moving average is 14.71, creating a Buy signal.
RAPT Therapeutics’s (RAPT) stock price is $30 and RAPT Therapeutics’s (RAPT) 200-day simple moving average is 11.70, creating a Buy signal.

RAPT Therapeutics (RAPT) Technical Indicators

Oct 25, 2025, 01:41 AM
Name
Value
Implied Action
RSI (14)
60.93
Neutral
STOCH (9,6)
44.93
Neutral
STOCHRSI (14)
44.93
Neutral
MACD (12,26)
3.07
Buy
ADX (14)
41.95
Neutral
Williams %R
-68.30
Buy
CCI (14)
85.05
Neutral
ATR (14)
3.53
-
Ultimate Oscillator
48.72
Neutral
ROC
3.09
Buy
RAPT Therapeutics’s (RAPT) Relative Strength Index (RSI) is 60.93, creating a Neutral signal.
RAPT Therapeutics’s (RAPT) Trend Strength Indicator (ADX) is 41.95, creating a Neutral signal.
RAPT Therapeutics’s (RAPT) Commodity Channel Index (CCI) is 85.05, creating a Neutral signal.
RAPT Therapeutics’s (RAPT) Price Rate of Change (ROC) is 3.09, creating a Buy signal.

FAQ

Is RAPT a Buy, Hold, or Sell?
Based on RAPT’s technical indicators, RAPT is a Strong Buy.
    What is RAPT’s RSI (14)?
    RAPT’s RSI (14) is 60.93, which suggests RAPT is a Neutral.
      What is RAPT’s MACD?
      RAPT’s MACD is 3.07, which suggests RAPT is a Buy.
        What is RAPT’s 5-day moving average?
        RAPT’s 5-day moving average is 31.09, which suggests RAPT is a Sell.
          What is RAPT’s 20-day moving average?
          RAPT 20-day moving average is 28.44, which suggests RAPT is a Buy.
            What is RAPT’s 50-day moving average?
            RAPT’s 50-day moving average is 19.88, which suggests RAPT is a Buy.
              What is RAPT’s 200-day moving average?
              RAPT’s 200-day moving average is 11.70, which suggests RAPT is a Buy.
                What is RAPT’s Williams % R (14)?
                RAPT’s Williams % R (14) is -68.30, which suggests RAPT is a Buy.
                  What is RAPT’s CCI (14)?
                  RAPT’s CCI (14) is 85.05, which suggests RAPT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis